Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Paris - Delayed Quote EUR

Amplitude Surgical SA (AMPLI.PA)

Compare
5.95
0.00
(0.00%)
At close: 5:35:02 PM GMT+2
Loading Chart for AMPLI.PA
  • Previous Close 5.95
  • Open 6.00
  • Bid --
  • Ask --
  • Day's Range 5.95 - 6.00
  • 52 Week Range 2.70 - 6.15
  • Volume 1,363
  • Avg. Volume 5,900
  • Market Cap (intraday) 287.826M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 297.50
  • EPS (TTM) 0.02
  • Earnings Date Mar 26, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Amplitude Surgical SA designs, develops, and markets products for orthopedic surgery in France and internationally. The company provides a range of orthopedic products for primary and revision surgery aimed at treating pathologies of the hip, knee, and lower extremities primarily for foot and ankle surgery. It also offers AMPLIVISION, a computer-assisted surgery system; the i.M.A.G.E., a single-use made-to-measure instrument system; and E.T.O.I.L.E, a technology platform for anterior approaches resulting in less-invasive surgery. The company exports its products through a network of distributors and agents in approximately 30 countries. It serves patients, surgeons, and healthcare facilities. Amplitude Surgical SA was founded in 1997 and is headquartered in Valence, France. Amplitude Surgical SA is a subsidiary of Auroralux SAS.

www.amplitude-surgical.com

389

Full Time Employees

June 30

Fiscal Year Ends

Recent News: AMPLI.PA

View More

Performance Overview: AMPLI.PA

Trailing total returns as of 4/11/2025, which may include dividends or other distributions. Benchmark is CAC 40 (^FCHI) .

YTD Return

AMPLI.PA
85.94%
CAC 40 (^FCHI)
3.74%

1-Year Return

AMPLI.PA
102.38%
CAC 40 (^FCHI)
11.45%

3-Year Return

AMPLI.PA
116.36%
CAC 40 (^FCHI)
8.37%

5-Year Return

AMPLI.PA
461.32%
CAC 40 (^FCHI)
57.64%

Compare To: AMPLI.PA

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: AMPLI.PA

View More

Valuation Measures

Annual
As of 4/10/2025
  • Market Cap

    285.43M

  • Enterprise Value

    385.24M

  • Trailing P/E

    262.37

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.63

  • Price/Book (mrq)

    3.01

  • Enterprise Value/Revenue

    3.55

  • Enterprise Value/EBITDA

    15.01

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.00%

  • Return on Assets (ttm)

    3.10%

  • Return on Equity (ttm)

    1.15%

  • Revenue (ttm)

    108.47M

  • Net Income Avi to Common (ttm)

    1.09M

  • Diluted EPS (ttm)

    0.02

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    19.78M

  • Total Debt/Equity (mrq)

    126.28%

  • Levered Free Cash Flow (ttm)

    -10.06M

Research Analysis: AMPLI.PA

View More

Company Insights: AMPLI.PA

Research Reports: AMPLI.PA

View More

People Also Watch